Deepa Jonnalagadda
Sanford Burnham Prebys Medical Discovery Institute(US)Discovery Institute(US)
Publications by Year
Research Areas
Sphingolipid Metabolism and Signaling, Lipid Membrane Structure and Behavior, Neuroinflammation and Neurodegeneration Mechanisms, Inflammasome and immune disorders, Cancer-related molecular mechanisms research
Most-Cited Works
- → THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors(2021)482 cited
- → The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors(2023)381 cited
- → Platelet secretion is kinetically heterogeneous in an agonist-responsive manner(2012)195 cited
- → Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other Disorders(2019)123 cited
- → A Functionally Defined In Vivo Astrocyte Population Identified by c-Fos Activation in a Mouse Model of Multiple Sclerosis Modulated by S1P Signaling: Immediate-Early Astrocytes (ieAstrocytes)(2018)57 cited
- → Granule-mediated release of sphingosine-1-phosphate by activated platelets(2014)44 cited
- → Single-Nucleus RNA-seq of Normal-Appearing Brain Regions in Relapsing-Remitting vs. Secondary Progressive Multiple Sclerosis: Implications for the Efficacy of Fingolimod(2022)26 cited
- → Ponesimod inhibits astrocyte‐mediated neuroinflammation and protects against cingulum demyelination via S1P 1 ‐selective modulation(2022)21 cited
- → A Soluble Epoxide Hydrolase Inhibitor, 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, Ameliorates Experimental Autoimmune Encephalomyelitis(2021)18 cited
- → CAQK, a peptide associating with extracellular matrix components targets sites of demyelinating injuries(2022)15 cited